After months of trials, three coronavirus vaccines have been approved by federal health officials and Minnesota's vaccination program is underway. Here is information about the progress of vaccinations in Minnesota and answers to questions you may have about vaccines and the state's strategy to vaccinate millions of Minnesotans. Jump to the FAQ.
Frequently Asked Questions
Which vaccines have been approved?
While more than 50 vaccine candidates have progressed to clinical trials with humans, two have been approved for emergency use by the U.S Food and Drug Administration. A vaccine developed by Pfizer and BioNTech was approved for those age 16 and older by the FDA on Dec. 11, and a second vaccine produced by Moderna was authorized for adults over the age of 18 Dec. 18. A single-dose vaccine produced by Johnson & Johnson was approved for those age 18 and older Feb. 27. A fourth vaccine developed by the University of Oxford and AstraZeneca could be ready for review in coming months.
The FDA on May 10 authorized use of the Pfizer-BioNTech vaccine for children age 12 and older. Centers for Disease Control and Prevention (CDC) advisers endorsed the use of the Pfizer vaccine in kids as young as 12 on May 12 and the CDC quickly accepted their recommendations, paving the way for shots to begin.
How do the vaccines work?
The Pfizer/BioNTech and Moderna vaccines use messenger RNA to instruct cells to create a harmless piece of the virus that causes COVID-19. This piece of "spike protein" is a key feature of the virus (you've likely seen COVID-19 depicted as a spiky ball). The body recognizes this spike protein as foreign and triggers an immune response to fend off future infection.
The Johnson & Johnson and AstraZeneca vaccines are called viral vector vaccines, using the adenovirus — a strain of the common cold found in chimpanzees — to deliver a piece of that spike protein into cells. This prompts an immune response to inoculate the recipient against infection.